Neurostimulation Approaches in the Treatment of Severe Anorexia Nervosa
Abstract
1921 13114
Neurostimulation Approaches in the Treatment of Severe Anorexia Nervosaby
Abstract
Psychiatry is seeking interventions that could reliably sustain weight gain and psychosomatic recovery of patients with severe anorexia nervosa (AN). Currently, patients with AN, even after receiving individually-tailored therapeutic interventions, often relapse following marginal weight restoration. Also, the evidence regarding the effectiveness of psychotropic medications in relieving and treating AN symptomology is limited. The research in the field is aiming to mitigate shortcomings associated with common pract [...] 1921 13114 |
Neonatal Hypoxic Ischemic Encephalopathy: An Updated Preclinical and Clinical ReviewAbstract
Hypoxic-ischemic encephalopathy is a major cause of death and disability in the newborn period. Experimental models have demonstrated that brain injury in hypoxic-ischemic encephalopathy occurs in two phases: primary energy failure and secondary energy failure. In primary energy failure, there is a cessation of oxidative metabolism and irreversible neuronal injury, followed by secondary energy failure due to glutamate release, elevation of intracellular calcium, reactive oxygen species formation, apoptotic cell dea [...] 2401 25869 |
Behavioral Disorders and Celiac Disease: Coincidence or Casualty?Abstract
This paper presents the case of a child diagnosed with both celiac disease and Asperger’s syndrome. The literature does not report this association to date, and the authors believe it to be a coincidence rather than a casualty. 1697 12293 |
Neurological Manifestations of the Celiac Disease in ChildrenAbstract
Gluten-related disorders (GRDs) represent a spectrum of diverse clinical manifestations triggered by the ingestion of gluten in genetically susceptible individuals. The most common and widely recognized diseases within this spectrum are celiac disease and non-celiac gluten sensitivity. The clinical manifestations are intestinal, but extraintestinal manifestations may also appear, such as neurological or psychiatric.
This work will specifically review the neurological or psychiatric manifestations that are more freq [...] 1833 16452 |
Neurological Manifestations of Celiac Disease and Non-Celiac Gluten Sensitivity and the Effect of a Gluten Free Dietby
Abstract
Celiac disease (CeD) is an immune-mediated enteropathy triggered by gluten ingestion and affects nearly 1% of the population worldwide. CeD has typically been associated with gastrointestinal symptoms such as diarrhea and abdominal pain; however, its extra-intestinal manifestations are becoming widely recognized. In particular, CeD patients may present with various neurological manifestations and oftentimes, without evidence of gastrointestinal symptoms. The pathophysiology behind these manifestations is not well k [...] 1907 21285 |
Prone Anesthesia for a Super-Super Morbidly Obese Patient Undergoing Neurosurgery: A Case Reportby
Abstract
Obesity is on the rise around the world, carrying along with it a wide range of comorbidities and complications. We report on a super-super morbidly obese 43-year-old female, with a body mass index (BMI) of 77.85 kg/m2 (173cm, 233kg), who presented for a scheduled suboccipital craniectomy with C-1 laminectomy secondary to symptoms from an Arnold-Chiari type-I malformation. Already a challenging type of surgery, due to the patient’s extreme BMI and positioning, the surgery became more difficult. There are many [...] 1740 14675 |
Synaptic Plasticity and Learning Processes: A Neuroeducation PerspectiveAbstract
The story of each individual is essentially the story of their learning processes and relationships from the moment they were born. Indeed, the story of learning processes is merely a constant stratification of experiences based on biological and neurofunctional features that are influenced by genetic and cultural factors and subject to environmental stimuli constantly reshaping their behaviour.Neuroscientific studies conducted over the past decades have highlighted a unique feature of the human nervous system, cal [...] 1777 12614 |
Neuroprotective Strategies in Glaucoma - Translation to Clinical TrialsAbstract
Neuroprotection in glaucoma is any medical treatment by which decline in visual function can be slowed or prevented by supporting the health and survival of neural cells, independent of lowering of intraocular pressure (IOP). This is achieved by targeting mechanisms to inhibit or delay retinal ganglion cell death and promote cell survival pathways. Despite demonstrating promising results in preclinical trials, many neuroprotective strategies have failed to show success in subsequent clinical trials. Of the clinical [...] 1979 19253 |
Non-linear Dynamics and Chaotic Trajectories in Brain-Mind Visual Experiences during Dreams, Meditation, and Non-Ordinary Brain Activity Statesby
Abstract
The present report discusses brain visual experiences in conditions of low degree of openness of the brain toward the environment, for example, while dreaming, during meditation, or in non-ordinary brain activity states such as under the effects of psychoactive substances, in the state of coma, or in other states of reduced sensory perception, among others. In the present report, for brevity, such states are referred to as brain-mind visual experiences, implying that such a visual activity is not one connected to t [...] 1736 12995 |
Increased Diurnal Salivary Cortisol and Morning Serum Triglycerides and Decreased Apo A1 Concentrations in Children and Adolescents with Clinical Depressionby
Abstract
Data available on possible associations of lipids, steroid levels, and depression are conflicting. This study investigated their possible associations in a sample of youth with depression. Ninety-eight youth with depression and individually matched healthy volunteers on the basis of age and sex were enrolled for the study. The two groups had nearly similar body mass index. After fasting overnight, they underwent blood sampling for triglycerides (TG), total cholesterol, low-density lipoprotein, high-density lipoprot [...] 1353 9721 |
TOP